Novel drug candidate compounds, which are currently unique in the world and likely to be effective in the treatment of malaria, have been produced at the Faculty of Pharmacy of the University of Debrecen. The outstanding achievement of the researchers involved has been recognized by a publication award by Gróf Tisza István Debreceni Egyetemért Alapítvány [Count István Tisza Foundation for the University of Debrecen].
News
A group of experts from the University of Debrecen are also among the participants of a European research and innovation project whose objective is to investigate the impact of climate change on the emergence of toxic mycotoxins, for example, in wheat and corn (maize). This project, based on an international collaboration, was made possible by the previous successful joint research efforts of the University of Debrecen and the National Food Chain Safety Office (Nébih - Nemzeti Élelmiszerlánc-biztonsági Hivatal).
The production of several new herbal preparations is in the pipeline due to the cooperation between the Faculty of Pharmacy of the University of Debrecen and the Tashkent Institute of Pharmacy, which has been developed in recent years. There are also plans to jointly research and develop bacteriophage-based pharmaceuticals.
The University of Debrecen and the Joint Institute for Nuclear Research have signed a cooperation agreement. The multidisciplinary international centre for basic research in nuclear physics and related science and technology invites researchers from Debrecen to participate in projects in its seven laboratories.
The latest research results in the field of historiography were presented by experts at the 3rd International Historiography Conference, organised by the Institute of History of the Faculty of Humanities of the University of Debrecen (DE) between 21-23 November. The three-day international conference was also the occasion for the presentation of a monograph on István Szabó, an outstanding Debrecen historian.
It was an assistant professor of the Department of Molecular and Nanopharmaceutics at the Faculty of Pharmacy of the University of Debrecen who became the recipient of the prize named Danubius Young Scientist Award 2024 from Hungary. Ágnes Rusznyák's chief research interests include the cellular effects of cyclodextrins and RNA carrier activity. Her findings have been published in several scientific journals.